Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 27, 2013
Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
Benjamin Gibert, Stéphanie Simon, Valeriya Dimitrova, et al.
Plos One
|
April 28, 2015
The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma
Fabiana Salm, Valeriya Dimitrova, André O von Bueren, et al.
Oxidative Medicine and Cellular Longevity
|
August 18, 2017
2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner
Zaira Leni, Paulina Ćwiek, Valeriya Dimitrova, et al.
Plos One
|
August 17, 2013
Analysis of the dominant effects mediated by wild type or R120G mutant of αB-crystallin (HspB5) towards Hsp27 (HspB1)
Stéphanie Simon, Valeriya Dimitrova, Benjamin Gibert, et al.
Oncotarget
|
November 18, 2014
RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification
Paulina Ćwiek, Zaira Leni, Fabiana Salm, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALL
Amy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Haematologica
|
May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemia
Amy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Nature Cell Biology
|
October 22, 2021
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma
Julia Frede, Praveen Anand, Noori Sotudeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in <i>BRAF</i>-Mutated Multiple Myeloma
Johannes M Waldschmidt, Jake A Kloeber, Praveen Anand, et al.
Leukemia
|
September 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma
Julia Frede, Julia C Poller, Kayleen Shi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 27, 2013
Peptide aptamers: tools to negatively or positively modulate HSPB1(27) function
Benjamin Gibert, Stéphanie Simon, Valeriya Dimitrova, et al.
Plos One
|
April 28, 2015
The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma
Fabiana Salm, Valeriya Dimitrova, André O von Bueren, et al.
Oxidative Medicine and Cellular Longevity
|
August 18, 2017
2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner
Zaira Leni, Paulina Ćwiek, Valeriya Dimitrova, et al.
Plos One
|
August 17, 2013
Analysis of the dominant effects mediated by wild type or R120G mutant of αB-crystallin (HspB5) towards Hsp27 (HspB1)
Stéphanie Simon, Valeriya Dimitrova, Benjamin Gibert, et al.
Oncotarget
|
November 18, 2014
RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification
Paulina Ćwiek, Zaira Leni, Fabiana Salm, et al.
Biorxiv : the Preprint Server for Biology
|
February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALL
Amy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Haematologica
|
May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemia
Amy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Nature Cell Biology
|
October 22, 2021
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma
Julia Frede, Praveen Anand, Noori Sotudeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2021
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in <i>BRAF</i>-Mutated Multiple Myeloma
Johannes M Waldschmidt, Jake A Kloeber, Praveen Anand, et al.
Leukemia
|
September 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma
Julia Frede, Julia C Poller, Kayleen Shi, et al.
Page
of 2